REPORT ID 6939

United States Pneumococcal Vaccines Market Report 2019

Publish Date
2019
Pages
120
Format
Electronic (PDF)

In this report, the United States Pneumococcal Vaccines market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Pneumococcal Vaccines in these regions, from   2019 to 2025 (forecast).

United States Pneumococcal Vaccines market competition by top manufacturers/players, with Pneumococcal Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Sanofi
    GSK
    Merck
    Eli Lilly
    AstraZeneca
    Abera
    S K Chemicals
    Beijing Minhai Biotechnology
    Baxter
    Biken
    Celgene Corporation
    Panacea Biotec
    Serum Institute of India
    Genentech
    Genocea Biosciences
    ImmunoBiology
    Lupin
    Nuron Biotech
    Biogen
    Valneva Austria
    Sinovac

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    PPSV 23
    PCV 7/13
    PCV 10
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    For Infants
    For Children (2-10)
    For Person (10-64)
    For The Old (?65)

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Pneumococcal Vaccines Market  Report 2019
1 Pneumococcal Vaccines Overview
    1.1 Product Overview and Scope of Pneumococcal Vaccines
    1.2 Classification of Pneumococcal Vaccines by Product Category
        1.2.1 United States Pneumococcal Vaccines Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Pneumococcal Vaccines Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 PPSV 23
        1.2.4 PCV 7/13
        1.2.5 PCV 10
    1.3 United States Pneumococcal Vaccines Market by Application/End Users
        1.3.1 United States Pneumococcal Vaccines Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 For Infants
        1.3.3 For Children (2-10)
        1.3.4 For Person (10-64)
        1.3.5 For The Old (?65)
    1.4 United States Pneumococcal Vaccines Market by Region
        1.4.1 United States Pneumococcal Vaccines Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Pneumococcal Vaccines Status and Prospect ( 2014-2024)
        1.4.3 Southwest Pneumococcal Vaccines Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Pneumococcal Vaccines Status and Prospect ( 2014-2024)
        1.4.5 New England Pneumococcal Vaccines Status and Prospect ( 2014-2024)
        1.4.6 The South Pneumococcal Vaccines Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Pneumococcal Vaccines Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Pneumococcal Vaccines ( 2014-2024)
        1.5.1 United States Pneumococcal Vaccines Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Pneumococcal Vaccines Revenue and Growth Rate ( 2014-2024)

2 United States Pneumococcal Vaccines Market Competition by Players/Suppliers
    2.1 United States Pneumococcal Vaccines Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Pneumococcal Vaccines Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Pneumococcal Vaccines Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Pneumococcal Vaccines Market Competitive Situation and Trends
        2.4.1 United States Pneumococcal Vaccines Market Concentration Rate
        2.4.2 United States Pneumococcal Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Pneumococcal Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Pneumococcal Vaccines Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Pneumococcal Vaccines Sales and Market Share by Region ( 2014-2019)
    3.2 United States Pneumococcal Vaccines Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Pneumococcal Vaccines Price by Region ( 2014-2019)

4 United States Pneumococcal Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Pneumococcal Vaccines Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Pneumococcal Vaccines Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Pneumococcal Vaccines Price by Type ( 2014-2019)
    4.4 United States Pneumococcal Vaccines Sales Growth Rate by Type ( 2014-2019)

5 United States Pneumococcal Vaccines Sales (Volume) by Application ( 2014-2019)
    5.1 United States Pneumococcal Vaccines Sales and Market Share by Application ( 2014-2019)
    5.2 United States Pneumococcal Vaccines Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Pneumococcal Vaccines Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 GSK
        6.3.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GSK Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Merck
        6.4.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merck Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Eli Lilly
        6.5.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Abera
        6.7.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Abera Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 S K Chemicals
        6.8.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Beijing Minhai Biotechnology
        6.9.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Baxter
        6.10.2 Pneumococcal Vaccines Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Baxter Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Biken
    6.12 Celgene Corporation
    6.13 Panacea Biotec
    6.14 Serum Institute of India
    6.15 Genentech
    6.16 Genocea Biosciences
    6.17 ImmunoBiology
    6.18 Lupin
    6.19 Nuron Biotech
    6.20 Biogen
    6.21 Valneva Austria
    6.22 Sinovac

7 Pneumococcal Vaccines Manufacturing Cost Analysis
    7.1 Pneumococcal Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pneumococcal Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pneumococcal Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pneumococcal Vaccines Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Pneumococcal Vaccines Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Pneumococcal Vaccines Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Pneumococcal Vaccines Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Pneumococcal Vaccines Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Pneumococcal Vaccines Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer